Zeta Surgical
| Company type | Private |
|---|---|
| Industry | Medical technology |
| Founded | 2018 |
| Founder | Jose Amich, Raahil Sha, William Gormley |
| Headquarters | Boston , United States |
Key people | Jose Amich (CEO), Raahil Sha (CTO), William Gormley (Neurosurgeon) |
| Products | ZETA platform, Zeta TMS Navigation System |
Zeta Surgical Inc. is a privately owned medical technology firm headquartered in Boston, Massachusetts, USA. Established in 2018 by Harvard alumni Jose Amich (CEO) and Raahil Sha (CTO), together with neurosurgeon William Gormley from Brigham and Women's Hospital, the company specializes in creating computer-assisted surgical solutions for neurosurgery and interventional neuroradiology.
Technology
The core technology developed by ZETA SURGICAL integrates computer vision and advanced artificial intelligence algorithms to enable real-time navigation during surgeries. Utilizing parallel computing techniques, their system performs image registration and tracks patients without the need for rigid head immobilization. Both preclinical and clinical evaluations have confirmed submillimeter precision across various procedures such as neurotrauma, intracerebral hemorrhage, brain biopsy, and transcranial magnetic stimulation.
Their primary offering, the ZETA platform, often referred to as a "GPS-like" tool for neurosurgical applications, obtained its initial 510(k) clearance from the US Food and Drug Administration in September 2023, authorizing its use in cranial operations. Further FDA approvals in 2024 broadened the device’s functional scope and compatibility with additional surgical instruments. Additionally, the Zeta TMS Navigation System achieved FDA clearance for navigated transcranial magnetic stimulation, maintaining submillimeter accuracy. In 2024, ZETA SURGICAL successfully conducted its inaugural multi-center clinical trial at both Singapore General Hospital and Tan Tock Seng Hospital. The company was honored with the iF Design Award and Good Design Award in 2023 and collaborates with Australian design agency Design + Industry.
In 2022, ZETA SURGICAL revealed its work on a focused ultrasound system designed for intracranial drug delivery guided by the ZETA platform. The firm is also affiliated with the Focused Ultrasound Foundation.
History
ZETA SURGICAL originated from the collaboration of Harvard undergraduates Jose Amich and Raahil Sha alongside William Gormley, a neurosurgeon associated with Harvard Medical School and Brigham and Women's Hospital. Both Amich and Gormley hold MBAs from the MIT Sloan School of Management. The company has attracted investment from notable backers such as Y Combinator, Artesian Hostplus VC, Innospark Ventures, Trevor Fetter, Gabriel Hammond, and Marc de Garidel. Its advisory board features prominent figures including Elad Levy and George Bickerstaff, the former CFO of Novartis Pharma AG.
Raahil Sha was distinguished as one of Harvard’s Most Interesting Seniors, while both founders earned recognition on the 2024 North American edition of the Forbes 30 Under 30 list.